Elodie Jambert
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Health-care provider compliance with a revised Plasmodium vivax radical cure algorithm incorporating tafenoquine and quantitative G6PD testing in the Peruvian Amazon: a prospective observational study.
Journal: Lancet regional health. Americas
Published: February 05, 2026
High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of Plasmodium vivax malaria: a safety study in Papua New Guinea and Indonesia.
Journal: The Lancet regional health. Western Pacific
Published: January 28, 2026
The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System.
Journal: Lancet regional health. Americas
Published: February 21, 2025
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.
Journal: Malaria journal
Published: May 02, 2024
Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
Journal: The Lancet. Infectious diseases
Published: November 07, 2023
Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
Journal: The Lancet. Global health
Published: July 25, 2023
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
Journal: Malaria journal
Published: March 05, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026